The ICT Based Prescription of Physical Activity for Oncology Patients at Their Home

Study evaluating the efficacy of ICT-based prescription of physical activity in oncology patients

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Federico II University

Naples, Italy

Location status: Recruiting

Location contact

Guido Iaccarino, Full Professor

CONTACT

[email protected]

+390817463697

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female patients affected by breast cancer eligible for adiuvant treatment
Male patients affected by prostatic cancer eligible for adiuvant treatment

Exclusion criteria

Active life stily before enrollment

Treatment and study plan

Primary outcomes

tollerance to exercise

Time frame: 6 months

10% increase in time of exercise

Study contacts

Contact information is provided by the study sponsor or research team.

Guido Iaccarino, Full Professor

CONTACT

[email protected]

+390817463697

Sponsors and collaborators

Lead sponsor

Federico II University

Other

Registry information

Official study title

The ICT Based Prescription of Physical Activity for Oncology Patients at Their Home: the EASYDOM Trial

Acronym: EASYDOM

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Jun 13, 2025
Registry last updated: Jun 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting